AstraZeneca, Abbott partner on combo drug

July 11 2006

AstraZeneca and Abbott Laboratories said they plan to co-develop and market a combination cholesterol drug.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.